SCHEMBL7645971

SCHEMBL7645971

CCS(=O)(=O)c1ccc(C2=C(c3ccccc3)C(=O)c3ccccc32)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSIP1 O75475 1/20 0.53
MITF O75030 1/20 0.47
ALDH1A1 P00352 1/20 0.47
MAPT P10636 1/20 0.47
HTT P42858 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
ESR1 P03372 2/20 0.46
ESR2 Q92731 2/20 0.46
CDC25A P30304 1/20 0.46
CDC25B P30305 1/20 0.46
PTGS2 P35354 3/20 0.46
PTPN1 P18031 1/20 0.46
HSP90AA1 P07900 2/20 0.45
HSP90AB1 P08238 2/20 0.45
MAPK14 Q16539 1/20 0.45
RORC P51449 2/20 0.45
FGFR1 P11362 3/20 0.44
FGFR2 P21802 3/20 0.44
FGFR4 P22455 3/20 0.44
FGFR3 P22607 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3252409 0.83 PTGS2 (0.68) ALDH1A1PTGS2
SCHEMBL293991 0.80 PSIP1 (0.74) PSIP1PTGS2RORCMMP2MMP7
SCHEMBL5134257 0.80 PSIP1 (0.74) PSIP1PTGS2RORCMMP2MMP7
SCHEMBL740371 0.80 FGFR1 (0.61) MITFALDH1A1MAPTHTTNPSR1
SCHEMBL5497788 0.76 MAPT (0.65) MITFALDH1A1MAPTHTTNPSR1
SCHEMBL13530669 0.74 PTGS2 (0.74) ALDH1A1PTGS2
SCHEMBL7878297 0.73 PTGS2 (0.62) MITFALDH1A1MAPTHTTNPSR1
SCHEMBL3252412 0.73 PTGS2 (0.49) MITFALDH1A1MAPTHTTNPSR1
SCHEMBL180713 0.72 PSIP1 (1.00) PSIP1ALDH1A1HTT
Fluoride SCHEMBL9493182 0.70 PSIP1 (0.95) PSIP1ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6403630-B1 ADMINISTERING A CYCLOOXYGENASE-2 (COX-2) INHIBITOR ALONE OR IN COMBINATION WITH HERCEPTIN? ANTIBODY; USED TO TREAT BREAST CANCER CORNELL RESEARCH FOUNDATION, INC. 2002-06-11 US disclosed